Monte Rosa Therapeutics Inc — Cash Flow (NASDAQ:GLUE) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 59.36 M92.47 M43.8 M42 M -24.71 M Cash from investing activities 9.65 M219.22 M88.8 M44.45 M 67.66 M Cash from financing activities 377.56 M20.47 M27.49 M98.89 M 1.33 M Free cash flow 49.63 M79.56 M24.76 M38.01 M -28.83 M

뉴스

Monte Rosa 주가, 전립선암 임상 시험 결과에 상승

Monte Rosa shares rise on prostate cancer trial results

몬테 로사, 전립선암 치료제 긍정적 임상 데이터 발표

Monte Rosa reports positive trial data for prostate cancer drug

NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates

몬테 로사 테라퓨틱스(GLUE) 목표 주가, 파이퍼 샌들러, $37로 상향 조정

Monte Rosa stock price target raised to $37 from $27.50 at Piper Sandler

몬테 로사 테라퓨틱스, 3억 달러 규모 공모 가격 결정

Monte Rosa Therapeutics prices $300 million public offering

GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug

Monte Rosa Therapeutics (GLUE) is on the Move, Here's Why the Trend Could be Sustainable

몬테 로사 테라퓨틱스, 2억 달러 규모 공모 개시